David Schrader

Vice President, Quality and Compliance

Professional Overview
David Schrader is an experienced quality and compliance professional with over 15 years of expertise in the pharmaceutical and life sciences industries. As the Vice President of Quality and Compliance at Lumos Pharma, he is responsible for leading the company's quality assurance and regulatory compliance efforts, ensuring the delivery of safe and effective products to patients.

Experience Summary

Current Role
In his current role as Vice President of Quality and Compliance at Lumos Pharma, David is responsible for developing and implementing comprehensive quality management systems, overseeing regulatory compliance, and managing cross-functional teams to drive continuous improvement. He has played a pivotal role in the successful launch of several of the company's pharmaceutical products, ensuring they meet the highest standards of quality and safety.

Career Progression
Prior to his current position, David held various quality assurance leadership roles at NewLink Genetics and Boehringer Ingelheim Vetmedica, where he consistently demonstrated his ability to optimize quality systems, enhance operational efficiency, and foster a culture of compliance. Throughout his career, he has contributed to the successful development and commercialization of numerous pharmaceutical and veterinary products, earning a reputation as a strategic and solutions-oriented quality professional.

Academic Background
David holds a Bachelor of Science degree in Chemistry from the University of Iowa, where he graduated with honors. He has also completed several industry-specific training programs and certifications, including Six Sigma Green Belt and Lean Manufacturing.

Areas of Expertise

• Quality assurance and control

• Regulatory compliance (cGMP, FDA, EMA)

• Pharmaceutical product development and launch

• Quality management system implementation

• Cross-functional team leadership and collaboration

• Continuous improvement and operational excellence

Professional Impact
During his tenure, David has led the successful implementation of quality management systems that have resulted in significant reductions in product defects and improved compliance with regulatory standards. He has also spearheaded the development of innovative quality tools and processes, which have been recognized for their positive impact on operational efficiency and customer satisfaction.

Conclusion
With his extensive experience, proven track record of success, and strong commitment to quality and compliance, David Schrader is a valuable asset to Lumos Pharma and the broader pharmaceutical industry. He is poised to continue driving excellence in quality assurance and regulatory compliance, ensuring that the company's products maintain the highest standards of safety and efficacy.